Back to RecallTracker
Health Canada Health products

Ezetrol (ezetimibe) and the Risks of Drug-Induced Liver Injury and Severe Cutaneous Adverse Reactions

Issued March 27, 2024
Issue
Ezetrol (ezetimibe) may cause serious adverse reactions, including drug-induced liver injury (DILI) and severe cutaneous adverse reactions (SCARs) such as Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and drug reaction with eosinophilic and systemic symptoms (DRESS).
Hazard description
Product safety
Product
Product name
Ezetrol (ezetimibe) 10 mg tablets
Reference
ID
RA-75292